. Author manuscript; available in PMC: 2023 Dec 1.

Published in final edited form as: J Bone Miner Res. 2022 Oct 5;37(12):2466–2471. doi: 10.1002/jbmr.4708

Table 4.

Final Cox regression model for the development of MRONJ

Parameter	Adjusted Hazard Ratio	95% CI	P
Age >=65 year	0.91	0.52-1.60	0.74
Female sex	1.22	0.64-2.32	0.55
Race (black vs. white)	0.74	0.34-1.62	0.46
Race (Hispanic/other vs. white)	0.49	0.15-1.59	0.23
Prior exposure to mTOR inhibitors	3.53	1.33-9.34	0.011
Dental surgery	8.57	2.61-28.11	0.0004
Denosumab vs. IV BP	1.25	0.66-2.34	0.49
IV BP/Denosumab vs. IV BP	4.49	1.96-10.28	0.0004